Kenneth J. Kay - 18 Mar 2026 Form 3 Insider Report for Genius Sports Ltd (GENI)

Reporting relationship: Director
Issuer ticker: GENI
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 18 Mar 2026, 17:34:34 UTC
Prior SEC filing: 22 May 2025
Next SEC filing: 21 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Carolyn Duncanson, Attorney-in-Fact

Key filing fact

Kenneth J. Kay filed Form 3 for Genius Sports Ltd (GENI) on 18 Mar 2026.

Key facts

This page summarizes Kenneth J. Kay's Form 3 filing for Genius Sports Ltd (GENI).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Mar 2026, 17:34.

Change

Previous filing in this sequence was filed on 22 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001292642 Primary reporting owner

Kay Kenneth J

Relationship: Director
Address: C/O GENIUS SPORTS LTD, 1ST FLOOR, 27 SOHO SQUARE, LONDON, UNITED KINGDOM
Signature: /s/ Carolyn Duncanson, Attorney-in-Fact
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GENI holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 131,281
Date: 18 Mar 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GENI holding Derivative

Restricted Share Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 28,701
Exercise price: $0.000000
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reported securities represent restricted share units ("RSUs"), which each represent the contingent right to receive one Ordinary Share, subject to the Reporting Person's continued service through the applicable vesting date.

Footnote F2

These RSUs were granted on December 11, 2025 and vest one year from the grant date.

SEC remarks

Exhibit List - Exhibit 24.1 Power of Attorney